Recent Updates
Recently added Catalysts
RGEN Positive Sentiment Score: 70/100

Repligen Corporation to Present at 41st Annual J.P. Morgan Healthcare Conference

Tuesday, January 3, 2023 1 min read
Key Takeaway: WALTHAM, Mass., Jan. 03, 2023 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that it will present at the 41st Annual J.P. Morgan Healthcare conference being held January 9-12 in San F

Market Sentiment Analysis

POSITIVE FACTORS

  • Repligen Corporation is presenting at a prestigious conference.
  • The event offers a platform for showcasing bioprocessing technology leadership.
  • Live webcast availability increases accessibility for investors.

Full Press Release Details

WALTHAM, Mass., Jan. 03, 2023 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that it will present at the 41st Annual J.P. Morgan Healthcare conference being held January 9-12 in San Francisco.  Tony J. Hunt, President and Chief Executive Officer, will present on Tuesday, January 10, 2023, at 2:15 p.m. PST.
A live webcast of the presentation will be accessible through the Investor Relations section of the Company’s website, and will be available for replay for a limited period of time following the conference event.
About Repligen Corporation
Global Head of Investor Relations
investors@repligen.com

Frequently Asked Questions

When is Repligen presenting at the J.P. Morgan Healthcare conference?

Repligen will present on January 10, 2023, at 2:15 p.m. PST.

Where can I watch Repligen's conference presentation?

The presentation will be available via a live webcast on their website.

Who is presenting for Repligen at the conference?

Tony J. Hunt, President and CEO, will present on behalf of Repligen.

How can I contact Repligen for investor relations?

You can reach Sondra S. Newman at investors@repligen.com.

Tags: RGEN Viatris Investor Conferences Healthcare Repligen J.P. Morgan Healthcare Conference bioprocessing technology investor relations
Last updated: Jan 3, 2023